Gsk (GSK) Exchange Rate Effect (2009 - 2026)

Gsk (GSK) has 18 years of Exchange Rate Effect data on file, last reported at -$6.7 million in Q3 2026.

• For the quarter ending Q3 2026, Exchange Rate Effect changed N/A year-over-year to -$6.7 million; the trailing twelve-month figure through Sep 2026 stood at -$67.1 million (changed N/A YoY), and the FY2025 full-year result was -$25.3 million, up 63.39% from the prior year.
• Exchange Rate Effect was -$6.7 million for Q3 2026 at Gsk, down from $2.7 million in the prior quarter.
• In the past five years, Exchange Rate Effect ranged from a high of $97.4 million in Q4 2022 to a low of -$109.2 million in Q4 2023.
• A 5-year average of -$15.9 million and a median of -$19.0 million in 2025 frame the typical range for Exchange Rate Effect.
• Across the five-year window, Exchange Rate Effect surged 312.41% in 2022 and plunged 334.01% in 2023, its largest moves.
• Gsk's Exchange Rate Effect stood at $97.4 million in 2022, then slumped by 212.19% to -$109.2 million in 2023, then soared by 68.27% to -$34.7 million in 2024, then sank by 42.02% to -$49.2 million in 2025, then surged by 86.36% to -$6.7 million in 2026.
• Per Business Quant data, the three most recent Exchange Rate Effect figures were -$6.7 million in Q3 2026, $2.7 million in Q1 2026, and -$49.2 million in Q4 2025.